These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9610461

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Can we preoperatively risk stratify ovarian masses for malignancy?
    Oltmann SC, Garcia N, Barber R, Huang R, Hicks B, Fischer A.
    J Pediatr Surg; 2010 Jan; 45(1):130-4. PubMed ID: 20105592
    [Abstract] [Full Text] [Related]

  • 4. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ, de Bruijn HW, Hollema H, ten Hoor KA, Willemse PH, Aalders JG, van der Zee AG.
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [Abstract] [Full Text] [Related]

  • 5. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
    Gaspar MJ, Diez M, Rodriguez A, Ratia T, Martin Duce A, Galvan M, Granell J, Coca C.
    Anticancer Res; 2003 Jul; 23(4):3427-32. PubMed ID: 12926084
    [Abstract] [Full Text] [Related]

  • 6. A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
    Guadagni F, Ferroni P, Carlini S, Mariotti S, Spila A, Aloe S, D'Alessandro R, Carone MD, Cicchetti A, Ricciotti A, Venturo I, Perri P, Di Filippo F, Cognetti F, Botti C, Roselli M.
    Clin Cancer Res; 2001 Aug; 7(8):2357-62. PubMed ID: 11489813
    [Abstract] [Full Text] [Related]

  • 7. Preoperative serum tumor-associated antigen levels in women with pelvic masses.
    Soper JT, Hunter VJ, Daly L, Tanner M, Creasman WT, Bast RC.
    Obstet Gynecol; 1990 Feb; 75(2):249-54. PubMed ID: 2300353
    [Abstract] [Full Text] [Related]

  • 8. Validation of referral guidelines for women with pelvic masses.
    Im SS, Gordon AN, Buttin BM, Leath CA, Gostout BS, Shah C, Hatch KD, Wang J, Berman ML.
    Obstet Gynecol; 2005 Jan; 105(1):35-41. PubMed ID: 15625139
    [Abstract] [Full Text] [Related]

  • 9. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer.
    Phocas I, Sarandakou A, Sikiotis K, Rizos D, Kalambokis D, Zourlas PA.
    Anticancer Res; 1996 Jan; 16(6B):3827-31. PubMed ID: 9042265
    [Abstract] [Full Text] [Related]

  • 10. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
    Ayhan A, Guven S, Guven ES, Kucukali T.
    Acta Obstet Gynecol Scand; 2007 Jan; 86(4):484-90. PubMed ID: 17486473
    [Abstract] [Full Text] [Related]

  • 11. Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology.
    Petri AL, Simonsen AH, Yip TT, Hogdall E, Fung ET, Lundvall L, Hogdall C.
    Acta Obstet Gynecol Scand; 2009 Jan; 88(1):18-26. PubMed ID: 19023702
    [Abstract] [Full Text] [Related]

  • 12. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
    Sreenarasimhaiah J, Lara LF, Jazrawi SF, Barnett CC, Tang SJ.
    JOP; 2009 Mar 09; 10(2):163-8. PubMed ID: 19287110
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relationship between tumor markers CEA and CA 15-3, TNM staging, estrogen receptor rate and MIB-1 index in patients with pT1-2 breast cancer.
    Lumachi F, Basso SM, Brandes AA, Pagano D, Ermani M.
    Anticancer Res; 2004 Mar 09; 24(5B):3221-4. PubMed ID: 15510614
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses.
    Chen DX, Schwartz PE, Li XG, Yang Z.
    Obstet Gynecol; 1988 Jul 09; 72(1):23-7. PubMed ID: 3164105
    [Abstract] [Full Text] [Related]

  • 17. [Diagnostic significance of preoperative determination of CA-125 serum levels in the differentiation of malignant and benign pelvic masses].
    Durdević S, Segedi D, Vejnović T, Radeka G.
    Med Pregl; 1992 Jul 09; 45(7-8):262-5. PubMed ID: 1344453
    [Abstract] [Full Text] [Related]

  • 18. [Usefulness of CEA, CA 15-3 and CA 125 tumor markers in the differential diagnostics of peritoneal effusion].
    Kiluk MS, Rółkowski R, Zawadzki RJ, Wojtukiewicz MZ.
    Pol Merkur Lekarski; 2002 Oct 09; 13(76):298-301. PubMed ID: 12557435
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma.
    Tomita M, Matsuzaki Y, Edagawa M, Shimizu T, Hara M, Onitsuka T.
    Ann Thorac Cardiovasc Surg; 2004 Apr 09; 10(2):76-80. PubMed ID: 15209547
    [Abstract] [Full Text] [Related]

  • 20. Use of the preoperative levels of CEA in patients with colorectal cancer.
    Marchena J, Acosta MA, Garcia-Anguiano F, Simpson H, Cruz F.
    Hepatogastroenterology; 2003 Apr 09; 50(52):1017-20. PubMed ID: 12845969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.